Alexandra Horvath, Bálint Zsidai, Shanga Konaporshi, Eleonor Svantesson, Eric Hamrin Senorski, Kristian Samuelsson, Nenad Zeba
{"title":"原发性腕背神经节的治疗——系统综述。","authors":"Alexandra Horvath, Bálint Zsidai, Shanga Konaporshi, Eleonor Svantesson, Eric Hamrin Senorski, Kristian Samuelsson, Nenad Zeba","doi":"10.1055/s-0042-1753542","DOIUrl":null,"url":null,"abstract":"<p><p><b>Purpose</b> The aim of this study was to compare the rates of recurrence and wound infection in patients with primary dorsal wrist ganglion treated with aspiration (with or without an injection of an additive), open excision, or arthroscopic resection. <b>Methods</b> This systematic review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines and registered on PROSPERO. Systematic electronic searches in PubMed (MEDLINE), EMBASE, Web of Science, and the Cochrane Library of Controlled Trials were performed on May 5, 2020, and June 1, 2021, respectively. All clinical studies written in English determining the recurrence and wound infection rates after treatment of primary dorsal wrist ganglion with aspiration, open excision, or arthroscopic resection in patients over the age of 16 years were eligible for inclusion. Quality assessment was guided by the Cochrane Collaboration's tool for randomized controlled trials (RCTs) and the methodological index for nonrandomized studies (MINORS) tool for observational studies. <b>Results</b> The literature searches resulted in 1,691 studies. After screening, five RCTs, enrolling 233 patients, and six observational studies, enrolling 316 patients with primary dorsal wrist ganglions were included. Quality assessment of the included RCTs and observational studies determined the existing level of evidence pertaining to primary dorsal wrist ganglion treatment to be low. About 11 studies reported on recurrence rate, which ranged between 7 and 72% for patients initially treated with aspiration (with or without an injection of an additive). In comparison, the recurrence rate for the open excision and arthroscopic resection groups ranged between 6 to 41% and 0 to 16%, respectively. Four studies investigated wound-related complications, for which zero infections were reported, irrespective of treatment. <b>Conclusion</b> The evidence summarized in this systematic review demonstrates a considerable variability in recurrence rate following aspiration and open or arthroscopic resection of a primary dorsal wrist ganglion. The greatest variability in recurrence was displayed among studies on aspiration. The overall infection rate after treatment of dorsal wrist ganglions seems to be low regardless of the treatment type. However, the divergent results of individual studies highlight a pressing need for prospective controlled trials assessing outcomes following dorsal wrist ganglion treatment. <b>Level of Evidence</b> Systematic review on level 1 to 4 clinical therapeutic studies.</p>","PeriodicalId":46757,"journal":{"name":"Journal of Wrist Surgery","volume":"12 2","pages":"177-190"},"PeriodicalIF":0.7000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010899/pdf/10-1055-s-0042-1753542.pdf","citationCount":"1","resultStr":"{\"title\":\"Treatment of Primary Dorsal Wrist Ganglion-A Systematic Review.\",\"authors\":\"Alexandra Horvath, Bálint Zsidai, Shanga Konaporshi, Eleonor Svantesson, Eric Hamrin Senorski, Kristian Samuelsson, Nenad Zeba\",\"doi\":\"10.1055/s-0042-1753542\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Purpose</b> The aim of this study was to compare the rates of recurrence and wound infection in patients with primary dorsal wrist ganglion treated with aspiration (with or without an injection of an additive), open excision, or arthroscopic resection. <b>Methods</b> This systematic review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines and registered on PROSPERO. Systematic electronic searches in PubMed (MEDLINE), EMBASE, Web of Science, and the Cochrane Library of Controlled Trials were performed on May 5, 2020, and June 1, 2021, respectively. All clinical studies written in English determining the recurrence and wound infection rates after treatment of primary dorsal wrist ganglion with aspiration, open excision, or arthroscopic resection in patients over the age of 16 years were eligible for inclusion. Quality assessment was guided by the Cochrane Collaboration's tool for randomized controlled trials (RCTs) and the methodological index for nonrandomized studies (MINORS) tool for observational studies. <b>Results</b> The literature searches resulted in 1,691 studies. After screening, five RCTs, enrolling 233 patients, and six observational studies, enrolling 316 patients with primary dorsal wrist ganglions were included. Quality assessment of the included RCTs and observational studies determined the existing level of evidence pertaining to primary dorsal wrist ganglion treatment to be low. About 11 studies reported on recurrence rate, which ranged between 7 and 72% for patients initially treated with aspiration (with or without an injection of an additive). In comparison, the recurrence rate for the open excision and arthroscopic resection groups ranged between 6 to 41% and 0 to 16%, respectively. Four studies investigated wound-related complications, for which zero infections were reported, irrespective of treatment. <b>Conclusion</b> The evidence summarized in this systematic review demonstrates a considerable variability in recurrence rate following aspiration and open or arthroscopic resection of a primary dorsal wrist ganglion. The greatest variability in recurrence was displayed among studies on aspiration. The overall infection rate after treatment of dorsal wrist ganglions seems to be low regardless of the treatment type. However, the divergent results of individual studies highlight a pressing need for prospective controlled trials assessing outcomes following dorsal wrist ganglion treatment. <b>Level of Evidence</b> Systematic review on level 1 to 4 clinical therapeutic studies.</p>\",\"PeriodicalId\":46757,\"journal\":{\"name\":\"Journal of Wrist Surgery\",\"volume\":\"12 2\",\"pages\":\"177-190\"},\"PeriodicalIF\":0.7000,\"publicationDate\":\"2023-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010899/pdf/10-1055-s-0042-1753542.pdf\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Wrist Surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1055/s-0042-1753542\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ORTHOPEDICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Wrist Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0042-1753542","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 1
摘要
目的:本研究的目的是比较原发腕背神经节患者接受抽吸(有或没有注射添加剂)、切开切除或关节镜切除的复发率和伤口感染。方法本系统评价按照系统评价和荟萃分析的首选报告项目(PRISMA)指南进行,并在PROSPERO上注册。分别于2020年5月5日和2021年6月1日在PubMed (MEDLINE)、EMBASE、Web of Science和Cochrane对照试验图书馆中进行系统的电子检索。所有以英文撰写的临床研究均符合入选条件,这些研究确定了16岁以上患者采用抽吸、切开切除或关节镜切除治疗原发性腕背神经节后的复发率和伤口感染率。质量评价采用Cochrane协作组织的随机对照试验(rct)工具和观察性研究的非随机研究方法学指数(minor)工具。结果文献检索结果为1691项研究。筛选后,纳入5项随机对照试验,纳入233例患者,6项观察性研究,纳入316例原发性腕背神经节患者。纳入的随机对照试验和观察性研究的质量评估表明,与原发性腕背神经节治疗有关的现有证据水平较低。大约有11项研究报告了复发率,在最初接受抽吸治疗(有或没有注射添加剂)的患者中,复发率在7%至72%之间。相比之下,开放切除组和关节镜切除组的复发率分别为6 - 41%和0 - 16%。四项研究调查了与伤口相关的并发症,无论治疗如何,均无感染报告。结论:本系统综述总结的证据表明,在抽吸和开放或关节镜下切除原发性腕背神经节后,复发率有相当大的差异。在有关误吸的研究中,复发的变异性最大。无论何种治疗方式,腕背神经节治疗后的总体感染率似乎都很低。然而,个别研究的不同结果表明,迫切需要前瞻性对照试验来评估腕背神经节治疗后的结果。对1 - 4级临床治疗性研究进行系统评价。
Treatment of Primary Dorsal Wrist Ganglion-A Systematic Review.
Purpose The aim of this study was to compare the rates of recurrence and wound infection in patients with primary dorsal wrist ganglion treated with aspiration (with or without an injection of an additive), open excision, or arthroscopic resection. Methods This systematic review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines and registered on PROSPERO. Systematic electronic searches in PubMed (MEDLINE), EMBASE, Web of Science, and the Cochrane Library of Controlled Trials were performed on May 5, 2020, and June 1, 2021, respectively. All clinical studies written in English determining the recurrence and wound infection rates after treatment of primary dorsal wrist ganglion with aspiration, open excision, or arthroscopic resection in patients over the age of 16 years were eligible for inclusion. Quality assessment was guided by the Cochrane Collaboration's tool for randomized controlled trials (RCTs) and the methodological index for nonrandomized studies (MINORS) tool for observational studies. Results The literature searches resulted in 1,691 studies. After screening, five RCTs, enrolling 233 patients, and six observational studies, enrolling 316 patients with primary dorsal wrist ganglions were included. Quality assessment of the included RCTs and observational studies determined the existing level of evidence pertaining to primary dorsal wrist ganglion treatment to be low. About 11 studies reported on recurrence rate, which ranged between 7 and 72% for patients initially treated with aspiration (with or without an injection of an additive). In comparison, the recurrence rate for the open excision and arthroscopic resection groups ranged between 6 to 41% and 0 to 16%, respectively. Four studies investigated wound-related complications, for which zero infections were reported, irrespective of treatment. Conclusion The evidence summarized in this systematic review demonstrates a considerable variability in recurrence rate following aspiration and open or arthroscopic resection of a primary dorsal wrist ganglion. The greatest variability in recurrence was displayed among studies on aspiration. The overall infection rate after treatment of dorsal wrist ganglions seems to be low regardless of the treatment type. However, the divergent results of individual studies highlight a pressing need for prospective controlled trials assessing outcomes following dorsal wrist ganglion treatment. Level of Evidence Systematic review on level 1 to 4 clinical therapeutic studies.